Llwytho...
Ibrutinib in PCNSL: The Curious Cases of Clinical Responses and Aspergillosis
In this issue of Cancer Cell, Lionakis et al. demonstrate that the combination of temozolomide, etoposide, doxorubicin, dexamethasone, rituximab, and the Bruton tyrosine kinase (BTK) inhibitor ibrutinib induced frequent responses in patients with primary central nervous system lymphoma but was assoc...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer Cell |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572136/ https://ncbi.nlm.nih.gov/pubmed/28552326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ccell.2017.05.004 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|